Bragging and Blushing
It is our belief that validity of Peptides International’s products are affirmed by our own researchers’ numerous publications utilizing products made in their own laboratories. We regularly feature them in the “PubCrawl” column in our weekly e-newsletter. One such paper, coauthored by PI's President and CEO Dr. Michael W. Pennington, was published in the Journal of Pharmaceutical Sciences, and marked as the “Most Original and Most Significant Scientific Findings” in that issue! The paper, titled, Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases, and is just further confirmation that PI is truly “The Disulfide-Rich Peptide Experts!” The titular peptide was synthesized in our labs.
Our motto for decades has been “Research today. Cures tomorrow.” It is why we do what we do for our research - and yours!